Press Releases

and/or
567 News Releases found
The Mortimer B. Zuckerman Research Center
MSKCC Receives Record Gift of $100 Million from Mortimer B. Zuckerman for Cancer Research Facility

Memorial Sloan Kettering Cancer Center (MSKCC) today announced a major commitment from publisher, real estate developer, and MSKCC Board member Mortimer B. Zuckerman of $100 million from his charitable trust toward Memorial Sloan Kettering's new cancer research facility, including a 23-story laboratory structure that opens this month. Mr. Zuckerman's donation is the largest single commitment by an individual in Memorial Sloan Kettering's history.
Yogi Berra with Memorial Sloan Kettering Pediatric Patients and Siblings
New York Yankees and Memorial Sloan Kettering Launch Yankees Universe

The New York Yankees and Memorial Sloan Kettering Cancer Center have announced a new and unprecedented initiative to raise funds to help support research and treatment for children with cancer.
Stephen D. Nimer
Protein Regulates Quiescent Blood Stem Cells that Are Linked to Enhanced Recovery from Radiation and Chemotherapy

Scientists have uncovered new information about what orchestrates the complex balance between blood stem cells and mature blood cells, a relationship that is often disrupted in leukemia. The results will lead to a better understanding of the behavior of leukemic cells and may have vital clinical applications for patients recovering from chemotherapy, radiation therapy, or bone marrow transplantation.
A doctor reviewing medical scans.
Chemotherapy Pumped Directly to the Liver Improves Survival for Patients with Colorectal Cancer That Has Spread to the Liver

A multi-institutional study led by Memorial Sloan Kettering Cancer Center (MSKCC) shows that patients whose colorectal cancer has spread to the liver and who received chemotherapy directly to the liver through a pump in the abdomen (an approach called Hepatic Arterial Infusion or HAI) fare better than those who received systemic (intravenously administered) chemotherapy.
Underutilized Treatment for Advanced Ovarian Cancer Found to Significantly Improve Survival

Women with Stage III ovarian cancer when treated with a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, survived almost a year longer than those who received IV chemotherapy alone.
Risk for Lung Cancer Varies Among Smokers

A study that shows lung cancer risk varies widely among smokers may help individuals and their doctors decide if voluntary screening is appropriate for them.
Computerized Tool Predicts Sarcoma Survival

In a development that holds promise for advancing the treatment of patients with sarcoma, researchers at Memorial Sloan Kettering Cancer Center have developed a new prognostic tool that is more accurate than any previously available for this disease.